SO MOVEMENT DISORDERS BROADLY REFERS TO A FIELD WITHIN NEUROLOGY WHERE WE DEAL WITH VARIOUS CONDITIONS SUCH AS PARKINSON’S DISEASE, ESSENTIAL TREMOR, HUNTINGTON’S DISEASE, ETC. SO WITH ...

This study suggests that regularly consuming kefir may be beneficial for slowing Alzheimer’s disease. Kefir is a versatile ...

Trontinemab is currently being studied in the Phase Ib/IIa Brainshuttle AD study assessing the safety, tolerability, ...

Corks and Forks event benefitting the Huntington’s Disease Society’s Albany chapter broke records. More than 300 people ...

New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle™ AD study – ...

In Huntington’s disease, a genetic error leads the protein huntingtin to form clumps in the brain, leading to involuntary ...

IoT helps to decentralise clinical trials, allowing them to become increasingly patient-centric and diverse while providing ...

New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa ...

Unlearn®, a leader in AI solutions for clinical trials, today announced results from a collaboration with remynd, a Belgium-based biotech company developing treatments for neurodegenerative diseases.

According to Brandy Sarrette, RDN, LDN, a clinical dietician with Baystate Health, “Intermittent fasting is an eating plan ...

The DVLA has a list of medical conditions that drivers must disclose or risk being fined up to £1,000 for not doing so ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...